🇺🇸 FDA
Pipeline program

Pretomanid

ZeNix (B-Pa-L) NC-007

Phase 3 small_molecule completed

Quick answer

Pretomanid for Tuberculosis, Pulmonary is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tuberculosis, Pulmonary
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials